Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Small Cell Lung Carcinoma × Clear all

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Phase EARLY_PHASE1 Recruiting

24 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06747832 2024-12-24

iNK-SCLC

Phase EARLY_PHASE1 Enrolling by invitation

10 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT05886075 2023-06-02

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

24 enrolled

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

iNK-SCLC

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors